Logo image of TSC

TRISTATE CAPITAL HLDGS INC (TSC) Stock Fundamental Analysis

NASDAQ:TSC - Nasdaq - US89678F1003 - Common Stock

30.58  -0.08 (-0.26%)

After market: 30.58 0 (0%)

Fundamental Rating

3

TSC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 394 industry peers in the Banks industry. TSC may be in some trouble as it scores bad on both profitability and health. TSC is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TSC had positive earnings in the past year.
TSC Yearly Net Income VS EBIT VS OCF VS FCFTSC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

1.2 Ratios

Industry RankSector Rank
ROA 0.61%
ROE 9.96%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TSC Yearly ROA, ROE, ROICTSC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2 4 6 8 10

1.3 Margins

The Operating Margin and Gross Margin are not available for TSC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 32.82%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TSC Yearly Profit, Operating, Gross MarginsTSC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

TSC has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for TSC is higher compared to a year ago.
TSC Yearly Shares OutstandingTSC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
TSC Yearly Total Debt VS Total AssetsTSC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B 10B

2.2 Solvency

A Debt/Equity ratio of 0.15 indicates that TSC is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
TSC Yearly LT Debt VS Equity VS FCFTSC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

9

3. Growth

3.1 Past

TSC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.22%, which is quite impressive.
The Earnings Per Share has been growing by 11.56% on average over the past years. This is quite good.
The Revenue has grown by 27.70% in the past year. This is a very strong growth!
TSC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.43% yearly.
EPS 1Y (TTM)49.22%
EPS 3Y1.15%
EPS 5Y11.56%
EPS Q2Q%37.14%
Revenue 1Y (TTM)27.7%
Revenue growth 3Y13.85%
Revenue growth 5Y14.43%
Sales Q2Q%31.33%

3.2 Future

The Earnings Per Share is expected to grow by 28.63% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 20.26% on average over the next years. This is a very strong growth
EPS Next Y21.81%
EPS Next 2Y26.79%
EPS Next 3Y27.8%
EPS Next 5Y28.63%
Revenue Next Year23.8%
Revenue Next 2Y20.54%
Revenue Next 3Y20.16%
Revenue Next 5Y20.26%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TSC Yearly Revenue VS EstimatesTSC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
TSC Yearly EPS VS EstimatesTSC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

TSC is valuated correctly with a Price/Earnings ratio of 16.01.
TSC is valuated rather cheaply when we compare the Price/Earnings ratio to 27.48, which is the current average of the S&P500 Index.
TSC is valuated reasonably with a Price/Forward Earnings ratio of 10.69.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.52, TSC is valued rather cheaply.
Industry RankSector Rank
PE 16.01
Fwd PE 10.69
TSC Price Earnings VS Forward Price EarningsTSC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TSC Per share dataTSC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

TSC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TSC's earnings are expected to grow with 27.80% in the coming years.
PEG (NY)0.73
PEG (5Y)1.38
EPS Next 2Y26.79%
EPS Next 3Y27.8%

More info and screens

0

5. Dividend

5.1 Amount

TSC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRISTATE CAPITAL HLDGS INC

NASDAQ:TSC (5/31/2022, 8:00:02 PM)

After market: 30.58 0 (0%)

30.58

-0.08 (-0.26%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-27 2022-04-27/amc
Earnings (Next)07-19 2022-07-19
Inst Owners2.6%
Inst Owner Change0%
Ins Owners0.94%
Ins Owner Change0%
Market Cap1.03B
Analysts72.5
Price Target30.26 (-1.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP9.5%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.01
Fwd PE 10.69
P/S 4.04
P/FCF N/A
P/OCF N/A
P/B 1.23
P/tB N/A
EV/EBITDA N/A
EPS(TTM)1.91
EY6.25%
EPS(NY)2.86
Fwd EY9.36%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.56
BVpS24.91
TBVpSN/A
PEG (NY)0.73
PEG (5Y)1.38
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 9.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 32.82%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.22%
EPS 3Y1.15%
EPS 5Y11.56%
EPS Q2Q%37.14%
EPS Next Y21.81%
EPS Next 2Y26.79%
EPS Next 3Y27.8%
EPS Next 5Y28.63%
Revenue 1Y (TTM)27.7%
Revenue growth 3Y13.85%
Revenue growth 5Y14.43%
Sales Q2Q%31.33%
Revenue Next Year23.8%
Revenue Next 2Y20.54%
Revenue Next 3Y20.16%
Revenue Next 5Y20.26%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A